This article has been updated from a previous version to provide further details and a comment from a company spokesperson. 
 
NEW YORK (GenomeWeb News) - Thirty-two ABI employees, 13 of whom are involved in the company’s LC-MS product line, are losing their jobs, the company revealed in its annual report filed with the US Securities and Exchange Commission last month.
 
The employees were notified by May 31 and are expected to be terminated by Dec. 31, the company said in the filing.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.